Back to Rankings

BFRI

BiofronteraF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BFRI vs peer average
30/100
BFRI vs. peer average (F vs. D)
Grade spread
B 2 · C 1 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MBRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $13.13M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMBRXMoleculin Biotech
BFRI
Biofrontera
MBRX
Moleculin Biotech
Grade
F
F
Momentum
18
67
Value
41
41
Sentiment
-
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs MBRX

BFRI / MBRX
Grade Position
Below peers
BFRI vs. peer average (F vs. D)
30/100
Momentum
18
MBRX
Value
41
BFRI
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BFRI
1
MBRX
Moleculin Biotech Inc Common
F
20/100
Even
2
CYCN
Cyclerion Therapeutics Inc Common
D
40/100
-1
3
PHIO
Phio Pharmaceuticals Corp Common
B
80/100
-3
4
GDTC
CytoMed Therapeutics Ltd Common
D
40/100
-1
5
LNAI
Lunai Bioworks Inc Common
F
20/100
Even
MBRX is the first peer returned for this comparison set.